A trial in which rosiglitazone and glipizide were compared supports earlier findings that rosiglitazone does not have an adverse effect on the progression of coronary atherosclerosis ...

Rosiglitazone maleate is an oral antidiabetic agent which acts primarily by increasing insulin sensitivity. Rosiglitazone maleate is used in the management of type 2 diabetes mellitus (also known ...

Both rosiglitazone and pioglitazone are members of the thiazolidinedione (TZD) chemical class, and are associated with various side effects, including weight gain, fluid retention and oedema ...

Rosiglitazone, a drug from the thiazolidinedione class, has been used to help control blood sugar levels in people with type ...

Objective: Published reports suggest that pioglitazone and rosiglitazone have different effects on lipids in patients with type 2 diabetes. However, these previous studies were either ...

Data Synthesis: Studies of glyburide and glipizide have found little or no transfer of these drugs across the placenta, whereas metformin and rosiglitazone cross readily. Animal studies have found ...